The authors describe a boy with precocious puberty due to adrenal hyperplasia associated with rickets, hypocalcemia, hyperphosphatemia, elevated PTH and alkaline phosphatase levels, and concentrations of 25-OH-D and 1,25-(OH)2D at the upper limit or above normal range. Treatment with hydrocortisone for 9 months did not normalize hypocalcemia and hyperphosphatemia. The addition of 1,25-(OH)2D3 (0.5-2 μg/day) to the corticoid treatment for 1 year was followed by a progressive normalization of plasma calcium, phosphorus, PTH and alkaline phosphatase concentrations with improvement of the osteomalacia on bone biopsy.
Get full access to this article
View all access options for this article.
References
1.
Eberlein WP, Bongiovanni AMCongenital adrenal hyperplasia with hypertension: unusual steroids pattern in blood and urine. J Clin Endocrinol1955 ;15:1531-4.
2.
Batista MC, Mendonca BB, Kater CE, et al. Spironolactone-reversible rickets associated with 11 β-hydroxysteriod dehydrogenase deficiency syndrome. J Pediatr1986;109:989-93.
3.
Drezner MK, Neelon FA, Jowsey J., Lebovitz HEHypothyroidism: a possible cause of osteomalacia. J Clin Endocrinol Metab1977;45:111-22.
4.
Drezner MK, Neelon FAPseudo-hypoparathyroidism. The metabolic basis of inherited disease. 5th ed. New York: McGraw Hill, 1983;1508-27.
5.
Prader A., Illig R., Heirli E.Eine besondere form der primäre vitamin-D-resistenten Rachitis mit Hypocalcämia und autosomal-dominantem Erbgang: die hereditäre Pseudo-Mangelrachitis. Helv Paediatr Acta1961;16:452-68.
6.
Brooks MH, Bell NH, Love L., et al. Vitamin D dependent rickets type II: resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med1978 ;298:996-9.
